CLEAN : AstraZeneca's new Sweden facility produces Covid-19 preventative treatment for high-risk people

The video tutorial covers the production process of biologic drugs, focusing on vial processing, aseptic filling, and packaging. It highlights the production of Ever Shelled, a preventive option for COVID-19, and discusses its evaluation by the European Medical Agency. The tutorial also provides an overview of the manufacturing site, which is a primary launch and commercial site for biologics, producing a significant volume for AstraZeneca.

What is the first step in the vial processing machine?

• Inserting stoppers into the vials

• Packaging the vials

• Labeling the vials

• Filling the vials with product

What is the purpose of the automated reading in the vial processing machine?

• To ensure the correct vials enter the machine

• To package the vials properly

• To fill the vials with the correct product

• To insert stoppers into the vials

What is the main purpose of using stoppers in the aseptic filling process?

• To prevent the product from leaking

• To ensure the correct product is filled

• To label the vials

• To avoid exposure to the external environment

What is 'ever shelled' currently undergoing in Europe?

• Market launch

• Regulatory evaluation

• Clinical trials

• Production increase

For which population is 'ever shelled' an option for COVID-19 prevention?

• 2% of the population at risk of inadequate vaccine response

• People with a proper vaccine response

• Children under 12

• The general population

Where is the primary launch site for the biologics portfolio mentioned in the transcript?

• France

• Germany

• United States

• Sweden

What percentage of the total volume is produced at the Atalia larger campus?

• 40%

• 30%

• 20%

• 10%